Shire (SHP)

Share price graph

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4589.50p Today's change: +0.77%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4589.50p 5 day change: -1.31%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4589.50p 6 month change: +4.14%

Contact details

Address: 22 Grenville Street, St Helier, Jersey
Phone: +44 (0) 1256 894 000
Fax: +44 (0) 1256 894 708
Website: www.shire.com

Company information

Drugs group Shire Pharmaceuticals is best known for the attention deficit disorder treatments Adderall and Vyvanse. Founded in 1986 and became a listed company in 1996.

Pharmaceutical stocks – one of the few sectors that was thought to be privately if not publicly hoping for a [...]

9 November 2016
Shares
2
Views
501

US seeds company Monsanto has accepted a takeover offer from German chemicals company Bayer, marking the biggest [...]

14 September 2016
Views
49

Pharmaceutical group Shire has reported a jump in sales in the six months to 30 June and predicts strong full-year [...]

8 August 2016
Shares
11
Views
518

The Bank of England is widely expected to cut interest rates for the first time in seven years this week as it [...]

1 August 2016
Shares
1
Views
194

Big pharma firm Shire's shares are shining today after it gained regulatory approval for a new dry eye treatment. [...]

12 July 2016
Views
143

The revolts came on the back of major uprisings at oil giant BP, miner Anglo American, energy firm Centrica and [...]

28 April 2016
Shares
4
Views
617

A last-hour surge saved the FTSE 100 from another unspectacular day, as the afternoon rally helped the blue chip [...]

6 April 2016
Views
65

It looks like new tax inversion rules killed the M&A star, after Pfizer confirmed it has killed off its [...]

6 April 2016
Shares
2
Views
423

The FTSE 100 started the day higher, edging up 0.6 per cent, before it dipped to 5,826 points at the end of [...]

18 January 2016
Shares
5
Views
211

A string of mega deals is set to provide welcome relief to the City after a rocky start to the year saw £85bn [...]

11 January 2016
Shares
6
Views
1,095

Pharmaceutical giant Shire has not given up hope in its proposed takeover of US drug firm Baxalta. [...]

20 December 2015
Shares
6
Views
1,321
2 November 2015
Shares
9
Views
337

Irish drug giant Shire Pharma­ceuticals is prepared to top up its offer to woo rival Baxalta to the negotiating [...]

17 August 2015
Shares
2
Views
620

Shire's attempt to buy Baxalta could prove successful, so long as the pharmaceutical company agrees to add an [...]

16 August 2015
Shares
4
Views
399

The board of Baxalta will come under renewed pressure to open takeover negotiations this week, following early [...]

10 August 2015
Views
252

Content tagged with "Shire"